Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype

OBJECTIVE—Pharmacogenomics is a key component of personalized medicine. The Israel Cardiovascular Events Reduction with Vitamin E Study, a prospective placebo-controlled study, recently demonstrated that vitamin E could dramatically reduce CVD in individuals with diabetes and the haptoglobin (Hp) 2-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asleh, Rabea, Blum, Shany, Kalet-Litman, Shiri, Alshiek, Jonia, Miller-Lotan, Rachel, Asaf, Roy, Rock, Wasseem, Aviram, Michael, Milman, Uzi, Shapira, Chen, Abassi, Zaid, Levy, Andrew P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2008
Materias:
Complications
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2551691/
https://ncbi.nlm.nih.gov/pubmed/18599520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-0450
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares